Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 06/27 10:00:12 pm
116.55 USD   +0.80%
06/27 DOW MOVERS : Jpm, pfe
06/25 JOHNSON & JOHNS : wants Pinnacle bellwethers stayed after $500m loss
06/22 JOHNSON & JOHNS : Announces Retirement of Louise Mehrotra and Appoin..
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

share with twitter share with LinkedIn share with facebook
share via e-mail
08/22/2012 | 12:13am CEST
   By Ben Fox Rubin 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
React to this article
Latest news on JOHNSON & JOHNSON
06/27 DOW MOVERS : Jpm, pfe
06/25 JOHNSON & JOHNSON : wants Pinnacle bellwethers stayed after $500m loss
06/22 JOHNSON & JOHNSON : Announces Retirement of Louise Mehrotra and Appointment of J..
06/21 JOHNSON & JOHNSON : Experts Call For New Strategies to Address Diabetes in Obese..
06/21 JOHNSON & JOHNSON : to Host Investor Conference Call on Second-Quarter Results
06/21DJCARLYLE : Hire Targets Health Care in China -- WSJ
06/20DJCarlyle Group Hires Former J&J Executive to Advise Asia Buyout Fund
06/20 JOHNSON & JOHNSON : For Chihuahuans, voting is taken seriously
06/20 AVITA MEDICAL : Appoints a COO and a VP of Sales and Marketing
06/20 JOHNSON & JOHNSON : CMA approves K-Y licence in UK to Thornton & Ross
News chart
Full-screen chart
Income Statement Evolution
More Financials